Palam Pharma Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 4.60 M
- Company Age 27 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.78 Cr
- Revenue Growth 35.74%
- Profit Growth 32.02%
- Ebitda 34.91%
- Net Worth 17.69%
- Total Assets 29.24%
About Palam Pharma
Palam Pharma Private Limited (PPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 December 1997 and has a history of 27 years and one month. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.60 M.
The company currently has active open charges totaling ₹4.78 Cr.
Tarunbhai Patel and Bharatkumar Patel serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24230GJ1997PTC033493
- Company No.
033493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Palam Pharma Private Limited offer?
Palam Pharma Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Antiallergic API, Anti Infective Drugs & Medicines, Malaria Medicine, Digestive System Drugs & Medicines, Dicyclomine Hydrochloride Medicine, Sexual Wellness Products, Fertility Enhancer.
Who are the key members and board of directors at Palam Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tarunbhai Patel  | Director | 24-Dec-1997 | Current |
| Bharatkumar Patel | Director | 24-Dec-1997 | Current |
Financial Performance of Palam Pharma.
Palam Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 35.74% increase. The company also saw a substantial improvement in profitability, with a 32.02% increase in profit. The company's net worth Soared by an impressive increase of 17.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Palam Pharma?
In 2021, Palam Pharma had a public holding of 14.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹47.80 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 4.78 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Jun 2022 | Hdfc Bank Limited | ₹4.78 Cr | Open |
How Many Employees Work at Palam Pharma?
Unlock and access historical data on people associated with Palam Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Palam Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Palam Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.